http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100918746-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-734 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2005-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100918746-B1 |
| titleOfInvention | Anti-A3 antibody |
| abstract | Providing an antibody or an antibody fragment thereof capable of binding to A33 and specifically attacking A33-expressing tumor cells using an immune system by ADCC or CDC, and which does not produce HAHA, and the antibody or antibody fragment thereof Providing an agent for the prevention or treatment of various malignant tumors, including solid tumors that are currently difficult to treat, including. An antibody or functional fragment thereof that can bind A33, hybridoma M10 (Accession Number: FERM BP-10107), M96 (Accession Number: FERM BP-10108), M165 (Accession Number: FERM BP-10106), N26 (Accession Number: FERM BP-10109), Q47 (Accession Number: FERM BP-10104), Q54 (Accession Number: FERM BP-10105) or R5 (Accession Number: FERM BP-10107) An antibody or functional fragment thereof, and a prophylactic or therapeutic agent for a tumor comprising said antibody or functional fragment thereof.n n n n A33, anti-A33 antibody, CDC, ADCC, malignant tumor drug, immune response |
| priorityDate | 2004-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 835.